The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis

BACKGROUND: The validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™) is a standardized severity assessment for use in clinical trials and registries for atopic dermatitis (AD). OBJECTIVES: To investigate the reliability, validity, responsiveness and within‐patient meaningful cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Eric L., Bissonnette, Robert, Paller, Amy S., King, Brett, Silverberg, Jonathan I., Reich, Kristian, Thyssen, Jacob P., Doll, Helen, Sun, Luna, DeLozier, Amy M., Nunes, Fabio P., Eichenfield, Lawrence F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804170/
https://www.ncbi.nlm.nih.gov/pubmed/35442530
http://dx.doi.org/10.1111/bjd.21615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804170/
https://www.ncbi.nlm.nih.gov/pubmed/35442530
http://dx.doi.org/10.1111/bjd.21615

Ejemplares similares